جستجوی استاد راهنمای دانشگاهی

Michael J. Apostolakosمشاهده پروفایل

استاد

• Critical Care Medicine
• Pulmonary Disease
• Sepsis Management
• +۵ مورد دیگر

Dr. Michael J. Apostolakos is a Professor of Medicine and holds leadership roles including Director of Adult Critical Care and Director of the Internal Medicine Critical Care Medicine Fellowship at the University of Rochester Medical Center. He also serves as Chief Medical Officer at Strong Memorial Hospital & Highland Hospital (SMH & HH), Georgia & Thomas Gosnell Professor in Quality and Safety, and Vice President of the Office of VP for Health Sciences at URMC. He is a member of the Alpha Omega Alpha Honor Medical Society and has received numerous awards for clinical excellence and teaching. Dr. Apostolakos completed his MD at SUNY Buffalo School of Medicine & Biomedical Sciences (1987), followed by an Internal Medicine residency and Pulmonary/Critical Care fellowship at the University of Rochester Medical Center. His research focuses on sepsis, acute respiratory distress syndrome (ARDS), and quality improvement in critical care. He has published extensively on topics like nitric oxide metabolism in sepsis, mechanical ventilation strategies, and biomarkers predicting outcomes. His work bridges clinical practice with translational research, emphasizing multimodal therapies and evidence-based guidelines. Key Awards: Arthur W. Bauman Teaching Award, multiple "Best Doctors in America" recognitions, and Rochester Business Journal Health Care Achievement Award Dr. Apostolakos has led educational initiatives, including directing the Fundamentals of Critical Care Support Course, and contributed to over 20 books chapters on critical care topics like sepsis management and weaning protocols. His leadership spans academic and clinical domains, shaping both patient care and future clinician training.

Anna Panchenkoمشاهده پروفایل

استاد

• Computational Biology
• Biophysics
• Bioinformatics
• +۷ مورد دیگر

Dr. Anna Panchenko is a Professor at Queen's University, holding appointments in the Department of Pathology and Molecular Medicine (School of Medicine, Faculty of Health Sciences) and the School of Computing (Faculty of Arts and Science). She is also a Senior Investigator at the Ontario Institute for Cancer Research (OICR) and holds a Tier I Canada Research Chair in Computational Biology and Biophysics. Her research focuses on understanding cancer progression mechanisms, particularly how genetic and epigenetic factors influence mutations and their effects on proteins, interactions, and chromatin dynamics. She employs computational methods, including machine learning and molecular dynamics simulations, to study nucleosome positioning, histone interactions, and mutagenesis processes. Education: PhD in Biophysics (Lomonosov Moscow State University, 1993), BSc in Biophysics (Lomonosov Moscow State University, 1989). Research Interests: Computational biology, epigenetics, cancer genomics, molecular modeling, and machine learning applications in biomedicine. Her work integrates hypothesis-driven and data-driven approaches to uncover molecular mechanisms underlying cancer development. Notable Awards: Tier I Canada Research Chair in Computational Biology and Biophysics. Collaborations: Cross-disciplinary collaborations with OICR, Vector Institute for AI, and Queen's Cancer Research Institute. Tools developed include HYDROID for footprinting analysis and MutaBind for predicting mutation impacts on protein interactions. Labs: Computational Biology and Biophysics Lab at Queen's University, focusing on cancer driver mutations and epigenetic mechanisms.

Shantu Aminمشاهده پروفایل

استاد

• Chemical Carcinogenesis
• Environmental Toxicology
• Drug Resistance Mechanisms
• +۳ مورد دیگر

Shantu Amin is a Professor in the Department of Pharmacology at the Pennsylvania State University College of Medicine, located in Hershey, PA. His research focuses on mechanisms of chemical carcinogenesis, particularly the role of polycyclic aromatic hydrocarbons (PAHs) and their mutagenic effects. He investigates structure-activity relationships of carcinogenic compounds and strategies for chemoprevention. Key areas include DNA adduct formation, environmental carcinogens like dibenzo[a,l]pyrene, and the interplay between microbial metabolites and host signaling pathways (e.g., Ah receptor activation). Recent work explores drug-tolerant persister cells in cancer therapy resistance and the development of novel therapeutic agents. Amin collaborates widely, with contributions to studies on bile acid metabolism, miRNA delivery systems, and the gut-lung axis. His work bridges basic science with translational research, aiming to reduce cancer morbidity through targeted interventions.

• Pediatric Endocrinology
• Type 1 Diabetes
• Autoantibodies
• +۴ مورد دیگر

Cecilia K Andersson is a Postdoctoral Researcher and Consultant specializing in Paediatric Endocrinology and Diabetes Research at Lund University, affiliated with the EXODIAB initiative (Excellence of Diabetes Research in Sweden). Her primary focus is on autoimmunity mechanisms in type 1 diabetes, particularly investigating islet cell antibodies, beta-cell function, and genetic factors influencing disease progression. She has contributed to studies on glucose tolerance in autoantibody-positive children and the role of tissue transglutaminase autoantibodies in diabetes pathogenesis. Research Interests Autoantibody profiling in pediatric autoimmune diabetes Beta-cell dysfunction and glucose metabolism HLA genotype correlations in autoimmune disorders Clinical biomarkers for diabetes risk stratification Secondary prevention strategies in high-risk populations Her work bridges basic immunology and clinical endocrinology, with recent studies exploring stress-induced gene expression in COPD patients. Collaborations include EXODIAB's multidisciplinary diabetes research network. Labs/Teams Active member of EXODIAB: Excellence of Diabetes Research in Sweden, collaborating with Lund University's Department of Pediatrics and clinical partners in pediatric endocrinology.

Lothar R. Schadمشاهده پروفایل

استاد

• Medical Imaging
• Radiology
• Magnetic Resonance Imaging (MRI)
• +۴ مورد دیگر

Prof. Lothar R. Schad is a Professor at the Medical Faculty Mannheim, Heidelberg University , leading the Computer Assisted Clinical Medicine department. His research focuses on advancing magnetic resonance imaging (MRI) techniques for oncological radiotherapy planning and monitoring, including sodium imaging, diffusion tensor imaging, and lung/perfusion imaging. The group operates 3×1.5T and 2×3T MRI systems, with access to a 9.4T animal MRI system. Key research areas include: Quantitative biomarker development for diagnosis and therapy monitoring Integration of multi-modal imaging (CT/MRI/PET) Development of high-resolution protocols for clinical applications Current projects involve translational studies using animal models (rat/mouse) and bioreactor systems. Collaborations exist with radiology, neurology, and cardiology departments. Recent work emphasizes physiological MRI (perfusion, diffusion, oxygenation) in abdominal organs and sodium imaging for tissue viability assessment. Notable contributions include ultra-high-resolution glomeruli imaging in rat kidneys (9.4T), clinical diffusion kurtosis applications, and lung perfusion/ventilation mapping at 1.5T. The team also develops image-guided interventions using robotic systems like ZEEGO.

Sara Auldمشاهده پروفایل

دانشیار

• Tuberculosis (TB) epidemiology
• HIV-TB co-infection
• Pulmonary immune responses
• +۴ مورد دیگر

Sara Auld, MD, MSc is an Associate Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine at Emory University School of Medicine. She holds an affiliation with the Department of Epidemiology and practices at Emory University Hospital Midtown, where she teaches medical students, residents, and fellows in the Medical ICU and pulmonary consult services. Her research focuses on TB epidemiology, HIV-TB co-infection, host immune responses (particularly alveolar macrophage function), and post-treatment lung complications. Dr. Auld completed her medical degree at Columbia University and residency at Massachusetts General Hospital, with prior service at the CDC as an Epidemic Intelligence Service Officer in TB prevention. Education: Bachelor’s in History, Stanford University MD, Columbia University College of Physicians and Surgeons MSc in Clinical Research, Emory University Laney Graduate School Research Interests: Her work bridges clinical epidemiology and immunology, investigating TB transmission dynamics, HIV’s impact on immune defenses against TB, and long-term pulmonary sequelae of TB treatment. Recent studies explore biomarkers for post-TB lung disease, spatial epidemiology of drug-resistant TB, and the role of alcohol use in impairing macrophage function. She leads initiatives to improve post-treatment care and advocate for global TB/HIV co-management strategies. Advising & Grants: While specific grant details are not listed, her research aligns with NIH-funded priorities in TB and HIV research. She mentors trainees through Emory’s clinical and epidemiology programs. Her work has informed international guidelines for post-TB care and pandemic response strategies. Labs/Teams: Collaborates with multidisciplinary teams including the Emory Tuberculosis Research Unit, Global Health Institute, and CDC. Active in international symposia on post-infectious pulmonary complications and host-directed therapies.

Zeinab Abdelrahmanمشاهده پروفایل

پژوهشگر ارشد

• Kidney Health
• Bioinformatics
• Machine Learning
• +۷ مورد دیگر

Zeinab Abdelrahman is a Research Fellow at Queen’s University Belfast (QUB), based in the School of Medicine, Dentistry and Biomedical Sciences within the Centre for Public Health. She holds a Ph.D. in clinical pharmacy from China Pharmaceutical University and has over four years of experience in molecular biology and bioinformatics. Her current research focuses on analyzing multi-omics data from the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA), investigating genetic variations in diabetic kidney disease and new-onset diabetes after transplantation (NODAT). Affiliations: Queen’s University Belfast, School of Medicine, Dentistry and Biomedical Sciences Roles: Research Fellow, Postdoctoral Researcher Her research interests encompass kidney health, bioinformatics, machine learning, molecular epidemiology, genomics, cancer research, and public health. She has contributed to over 26 peer-reviewed publications and actively participates in collaborative projects, including organizing events like the Kidney Canvas festival. Her work aligns with UN Sustainable Development Goals related to health equity and innovation. In 2024, she received the prestigious Dr Jennifer McCaughan Bursary award recognizing her contributions to medical research. Her recent work emphasizes data-driven approaches to unravel complex disease mechanisms and improve clinical outcomes in transplant recipients and aging populations.

• Immunology
• COVID-19 Research
• Respiratory Disorders
• +۵ مورد دیگر

Lynn Martinez is a Researcher at the University of Leicester's College of Medicine, Biological Sciences and Psychology, specializing in the Department of Infection, Immunity and Inflammation. With 55 citations to her name, she has established herself as a significant contributor to post-COVID-19 research through major collaborative projects including the PHOSP-COVID Study and ISARIC4C Investigators. Her research focuses on the immunological and respiratory consequences of SARS-CoV-2 infection, particularly examining accelerated immune aging in relation to disease severity, determinants of recovery from post-COVID dyspnea, and the relationship between sleep disturbances and impaired lung function following hospitalization. Martinez has contributed to several high-impact publications in journals including Immunity and Ageing , The Lancet Regional Health - Europe , and The Lancet Respiratory Medicine . Her work contributes to UN Sustainable Development Goals related to good health and well-being, particularly in understanding long-term health consequences of viral pandemics. Martinez's research spans multiple disciplines including immunology, respiratory medicine, sleep science, and epidemiology, with her most recent work extending into particle physics through the T2K Collaboration. Martinez has collaborated extensively with researchers across the UK and internationally, contributing to large-scale studies that have been widely disseminated, with her work picked up by 73 news outlets and shared across various social media platforms including X (formerly Twitter), Facebook, and Mendeley.

• Health Informatics
• Distributed Decision Support
• Medical Imaging Analytics
• +۳ مورد دیگر

Teresa Wu is a Professor and Associate Dean of Global Engagement at the Fulton Schools of Engineering, Arizona State University (ASU). She holds a joint appointment as a Professor in the School of Computing and Augmented Intelligence and serves as a Health Solutions Ambassador in the College of Health Solutions. Her expertise spans Health Informatics, Distributed Decision Support, and Medical Imaging Analytics. Wu earned her Ph.D. in Industrial Engineering from the University of Iowa and holds M.S. and B.S. degrees in Mechanical Engineering from Beihang University, China. Wu’s research focuses on medical imaging analytics, distributed decision systems, and information systems applications. She leads the ASU-Mayo Center for Innovative Imaging and has pioneered work in MRI-based kidney pathology tracking and headache classification using AI. Her awards include the NSF CAREER Award (2003) and recognition as an ASU Tenure and Promotion Exemplar (2006). Her grants include leadership roles in projects such as the $10M NIH-funded study on post-traumatic headache mechanisms and the NSF-funded CYDRES initiative securing smart buildings. She has advised numerous interdisciplinary collaborations, including work on sleep disorder monitoring and grid-interactive building cybersecurity. Education: Ph.D. Industrial Engineering (University of Iowa), M.S. & B.S. Mechanical Engineering (Beihang University). Awards: NSF CAREER Award, ASU Tenure Exemplar. Labs/Teams: ASU-Mayo Center for Innovative Imaging, CYDRES (Building Cyber Defense).

• MRI Techniques
• Hepatology
• Neuroimaging
• +۴ مورد دیگر

Eamon K. Doyle is an Assistant Professor of Clinical Radiology at the University of Southern California, Department of Radiology. His work focuses on advancing MRI techniques for clinical applications in hematology, neurology, and hepatology, with particular emphasis on iron overload disorders, cerebrospinal fluid dynamics, and disease-specific imaging biomarkers. Research Interests include: Development of quantitative MRI methods for iron quantification in liver and pancreas Neuroimaging of Chiari malformations and hydrocephalus Applications of MRI in sickle cell disease and retinoblastoma Optimization of clinical diagnostic workflows using advanced imaging techniques Recent publications highlight innovations in CSF flow measurement, pituitary siderosis assessment, and improving liver iron calibration. His work bridges investigative research and high-volume clinical imaging. Notably, Dr. Doyle has contributed to understanding transfusion-dependent sickle cell disease pathophysiology through pancreatic iron studies and pioneered techniques like Time-STAMP MRI for neurosurgical evaluation. Current research trends emphasize translational applications of MRI technologies across multiple organ systems. No academic awards or grants are explicitly listed in the provided materials. He has no listed advisees, though collaborations are evident through co-authored works. His work is affiliated with the USC Radiology Department and CTSI initiatives.

• Ovarian Cancer Biology
• BRCA Mutations
• Molecular Diagnostics
• +۳ مورد دیگر

Louis Dubeau, MD, PhD is a Professor of Pathology at the Keck School of Medicine, University of Southern California, where he directs the Molecular Diagnostics Laboratory at the USC/Norris Comprehensive Cancer Center. A native of Canada, he joined USC as a post-doctoral fellow and has since established himself as a leading researcher in ovarian cancer biology and molecular diagnostics. Dr. Dubeau's research spans ovarian cancer genetics , BRCA mutation mechanisms , endoplasmic reticulum stress pathways , and environmental health impacts such as air pollution effects. His work integrates molecular pathology with translational approaches to understand carcinogenesis and develop novel therapeutic strategies. Recent publications reveal a strong focus on viral pathogenesis (particularly SARS-CoV-2), epigenetic modifications in cancer prevention, and stress response proteins in tumor development. His laboratory has secured over $14 million in research funding, with publications spanning oncology, virology, and environmental health. Dr. Dubeau actively contributes to medical education through lectures across multiple continents and has mentored more than 50 students through PhD advisory roles and graduate training programs. As Director of the Molecular Diagnostics Laboratory, he oversees advanced diagnostic testing at both Keck Hospital of USC and USC Norris Cancer Hospital, bridging clinical practice with cutting-edge research in cancer genomics and molecular pathology.

• Cancer prevention
• Oral cancer
• Head and neck cancer
• +۵ مورد دیگر

Scott Lippman is a Professor of Medicine at the University of California San Diego School of Medicine, with appointments in the Divisions of Hematology-Oncology and Bone Marrow Transplantation. His research spans cancer prevention, precision oncology, and immunotherapy with a particular focus on head and neck cancers and precancerous lesions. Dr. Lippman's research interests center on molecular-based cancer prevention strategies, particularly for oral and head and neck cancers. He has pioneered work in chemoprevention, precancer biology, and the translation of molecular findings into clinical applications. His work has significantly contributed to understanding signaling vulnerabilities in cancer development and identifying targets for cancer interception. His recent publications demonstrate a strong focus on precision oncology approaches, including molecular tumor boards for rare cancers, AI applications in cancer diagnostics, and understanding immune responses in cancer development. His work bridges basic science discoveries with clinical applications in cancer prevention and treatment. Dr. Lippman has served as Principal Investigator on numerous NIH-funded research projects, including multiple R01 grants focused on oral cancer prevention and molecular-based therapy. His research has been continuously funded by the National Institutes of Health for decades, demonstrating the significance and impact of his work in the field of cancer prevention and precision medicine.

• Cardiology
• Cardiovascular Diseases
• Hypertension
• +۳ مورد دیگر

Marcin Gruchała is a Professor and Head of the 1st Department of Cardiology at the Medical University of Gdańsk, Poland. He specializes in cardiovascular medicine, with a focus on heart failure, lipid metabolism, coronary artery disease, and interventional cardiology. His work spans clinical research, translational medicine, and healthcare policy. Academically, he earned his doctoral degree in 2000 and became an assistant professor in 2006 before advancing to full professor in 2016. He leads research teams in heart failure and clinical trials at the Medical University of Gdańsk. His research interests include atherosclerosis mechanisms, lipoprotein(a) biology, and the impact of cardiovascular therapies on outcomes. Notable areas include lipid-lowering strategies, transcatheter interventions, and post-transplantation care. His articles reflect expertise in coronary interventions, pandemic-related healthcare challenges, and biomarker development. He has contributed to multidisciplinary guidelines on dyslipidemia and atherosclerotic disease management. He is a member of research teams focusing on heart failure (Team IV) and clinical innovation (Team X). His achievements include over 710 publications, 11 promoted theses, and participation in 3 major projects.

• Medical Imaging
• Biomedical Engineering
• Image Processing
• +۴ مورد دیگر

Maciej ORKISZ is a Professor at the Institute of Technology (IUT) of Claude Bernard Lyon 1 University , specializing in Mechanical Engineering and Production. With a career spanning over three decades, he has held academic roles at institutions including INSA Lyon (1992-2004) and INP Grenoble (1990-1992). His research focuses on medical imaging, particularly motion analysis in image sequences and 3D pulmonary/vascular image processing, with applications in ARDS, COPD, and cardiovascular diagnostics. Habilitation à Diriger les Recherches (2003), PhD in Automatics (1990), DEA in Signal Processing (1986), and Electronics Engineering (1985) Current responsibilities include co-leading the MYRIAD team at CREATIS lab and managing international academic collaborations (France-Colombia, France-Poland) His work bridges biomedical engineering and computer science, emphasizing CT image analysis for lung recruitability assessment, carotid artery segmentation in ultrasound, and machine learning applications in vascular diagnostics. Key projects include the development of the CreaTools framework for medical imaging software and studies on ventilation-induced lung injury. Scientific output includes over 40 publications (2010-2025) in areas like: ARDS and PEEP optimization via CT imaging Carotid artery wall motion analysis GAN-based ultrasound texture simulation Kinetic modeling of lung inflammation Automated vascular segmentation algorithms

• Oncology
• Lung Cancer
• Drug Resistance Mechanisms
• +۳ مورد دیگر

Zachary Yochum, MD, PhD, is a Clinical Assistant Professor in the Department of Internal Medicine at Yale School of Medicine, specializing in Medical Oncology and Hematology. His research focuses on molecular mechanisms of drug resistance in oncogene-driven cancers, particularly lung and renal cell carcinomas, with an emphasis on EMT transcription factors (TWIST1, ZEB1), HGF/MET pathways, and novel therapeutic strategies. Yochum holds a BS from the University of Notre Dame (2012), MD and PhD from the University of Pittsburgh School of Medicine (2020). He completed residency at Brigham and Women's Hospital and a postdoctoral fellowship funded by the HHMI Medical Research Fellowship and NIH grants. His research interests include developing targeted therapies against EGFR inhibitor resistance, immunotherapy rechallenge strategies, and understanding circRNA regulation in tumor progression. He has published widely in journals like Oncogene , Clinical Cancer Research , and The Lancet . Awards : HHMI Medical Research Fellowship (2014), F30 Ruth L. Kirschstein Fellowship (2017), Alpha Omega Alpha (2019) Yochum collaborates with teams investigating tumor microenvironment interactions, MET pathway activation, and biomarker-driven clinical trials. He is part of translational research initiatives at Yale focused on precision oncology and drug resistance mechanisms.